Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure
Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure
觀看 CytoSorbents;Hearing Zacks Small-Cap Research 設定了 6 美元的目標股價;CytoSorbents 公佈了 2023 年第二季度的財務和經營業績,顯示產品收入強勁增長,成本結構有所改善
Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure
觀看 CytoSorbents;Hearing Zacks Small-Cap Research 設定了 6 美元的目標股價;CytoSorbents 公佈了 2023 年第二季度的財務和經營業績,顯示產品收入強勁增長,成本結構有所改善